Table 2.
CXCL16 and CXCR6 expression as predictors of disease-specific survival in 335 NSCLC patients
| Characteristics | Patients, N (%) | Median survival (months) | 5-year survival (%) | P |
|---|---|---|---|---|
| CXCL16 | ||||
| Cancer cells | .080 | |||
| High | 48 (14) | NR | 67 | |
| Low | 227 (68) | 98 | 56 | |
| Missing | 60 (18) | |||
| Stromal cells | .016 | |||
| High | 258 (77) | 57 | 48 | |
| Low | 43 (13) | 189 | 62 | |
| Missing | 34 (10) | |||
| CXCR6 | ||||
| Cancer cells | .093 | |||
| High | 41 (12) | 190 | 73 | |
| Low | 245 (73) | 122 | 55 | |
| Missing | 49 (15) | |||
| CXCL16 | ||||
| Cancer cells + | .016 | |||
| stromal cells combined | ||||
| High/High | 43 (13) | NR | 71 | |
| High/Low | 182 (54) | 190 | 58 | |
| Low/Low | 41 (12) | 47 | 48 | |
| Missing | 69 (21) |
NR, not reached; NCSLC, non-small cell lung cancer